CLINICAL_TRIALS
trial_result
· 2006-07-11
Clinical Trial Update: Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer [Phase 2]
Summary
Phase 2 clinical trial of Tezacitabine with Oxaliplatin for metastatic colorectal cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chiron Corporation | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED